Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Dedicated

- PMLiVE

The M&A trend in pharma

Are pharma deals back in fashion or is big pharma in retreat and needing to reshape

Bayer symbol

Bayer to spin out material science division

German firm will focus solely on life sciences

- PMLiVE

Novo Nordisk’s Xultophy diabetes combo approved in Europe

Once-daily injection combines the firm's Tresiba and Victoza

- PMLiVE

FDA approves Lilly’s GLP-1 diabetes drug Trulicity

The once-weekly treatment is set to compete with Bydureon, Tanzeum and Victoza

- PMLiVE

Aurora expands its team with three new hires

Claire Mosley, Kristen Barrett and Joe Balfour join the London comms agency

- PMLiVE

NICE fast-tracks GSK’s skin cancer drug Tafinlar

But only on condition the company cuts its price

Boehringer Ingelheim headquarters

Boehringer signs €465m lung cancer vaccine deal

Licenses CureVac's cancer immunotherapy CV9202

Merck KGaA shakes up pharma leadership

Stefan Oschmann becomes deputy CEO as Belén Garijo assumes more responsibility

Sanofi reception

Sanofi licenses cardiomyopathy programme in $200m deal

Has rights to three of MyoKardia’s programmes

- PMLiVE

Pfizer acquires option to license potential Parkinson’s treatment

Medgenesis cuts exclusive deal for its GDNF treatment

- PMLiVE

FDA approves AZ’s opioid-induced constipation drug Movantik

Trials showed positive reactions to the treatment

- PMLiVE

Eric Hansen takes the helm at PAN

He replaces Jon Linscott as MD at the UK creative agency

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links